Ozempic Wars | The Next Injection | 2
Episode 2 of the Business Wars podcast, hosted by Audible, titled "Ozempic Wars | The Next Injection | 2" was published on November 26, 2025 and runs 36 minutes.
November 26, 2025 ·36m · Business Wars
Summary
Novo Nordisk can't keep up with demand for Ozempic and Wegovy, giving competitor Eli Lilly the edge in the GLP-1 market. And off-brand competitors continue to hammer the company's market position. Layoffs and board resignations signal that Novo Nordisk has entered a downward spiral. But with new leaders, acquisitions and deals, can they force a comeback? See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Episode Description
Novo Nordisk can't keep up with demand for Ozempic and Wegovy, giving competitor Eli Lilly the edge in the GLP-1 market. And off-brand competitors continue to hammer the company's market position. Layoffs and board resignations signal that Novo Nordisk has entered a downward spiral. But with new leaders, acquisitions and deals, can they force a comeback?
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Similar Episodes
Oct 13, 2022 ·27m
Dec 9, 2020 ·46m
Nov 16, 2020 ·34m
Oct 21, 2020 ·35m
Oct 21, 2020 ·38m
Oct 21, 2020 ·41m